Sensitive measures of executive dysfunction in non-demented Parkinson's disease

Parkinsonism and Related Disorders

Volumn 20, Issue 12, 2014, Pages 1430-1433

  Bott, Nicholas T ^a   Johnson, Erica T ^a   Schuff, Norbert ^a,b   Galifianakis, Nicholas ^b   Subas, Trishna ^a   Pollock, Jessica ^a,b   Pressman, Peter ^a   Kramer, Joel H ^a   Possin, Katherine L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cognitive control; Executive function; Mild cognitive impairment; Parkinson's disease; Working memory

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; EXECUTIVE FUNCTION; FEMALE; HUMAN; LANGUAGE ABILITY; MALE; NIH EXAMINER; NONDEMENTED PARKINSON DISEASE; PARKINSON DISEASE; SCORING SYSTEM; SENSITIVITY ANALYSIS; WORKING MEMORY; AGED; CHI SQUARE DISTRIBUTION; COGNITION DISORDERS; COMPLICATION; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SHORT TERM MEMORY; VERBAL BEHAVIOR;

AGED; CHI-SQUARE DISTRIBUTION; COGNITION DISORDERS; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; VERBAL BEHAVIOR;

EID: 84915805453     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.10.007     Document Type: Article

References (16)

1. Litvan I., Aarsland D., Adler C.H., Goldman J.G., Kulisevsky J., Mollenhauer B., et al. MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord 2011 Aug 15, 26(10):1814-1824. PubMed PMID: 21661055. Pubmed Central PMCID: 3181006.
2. Aarsland D., Bronnick K., Williams-Gray C., Weintraub D., Marder K., Kulisevsky J., et al. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 2010 Sep 20, 75:1062-1069.
3. Wesnes K.A., McKeith I., Edgar C., Emre M., Lane R. Benefits of rivastigmine on attention in dementia associated with Parkinson disease. Neurology 2005 Nov 22, 65(10):1654-1656. PubMed PMID: 16301500.
4. Possin K.L., Kang G.A., Guo C., Fine E.M., Trujillo A.J., Racine C.A., et al. Rivastigmine is associated with restoration of left frontal brain activity in Parkinson's disease. Mov Disord 2013 Sep, 28(10):1384-1390. PubMed PMID: 23847120.
5. Janvin C.C., Larsen J.P., Aarsland D., Hugdahl K. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord 2006 Sep, 21(9):1343-1349. PubMed PMID: 16721732.
6. Vossius C., Larsen J.P., Janvin C., Aarsland D. The economic impact of cognitive impairment in Parkinson's disease. Mov Disord 2011 Jul, 26(8):1541-1544. PubMed PMID: 21538519.
7. Litvan I., Goldman J.G., Troster A.I., Schmand B.A., Weintraub D., Petersen R.C., et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord 2012 Mar, 27(3):349-356. PubMed PMID: 22275317. Pubmed Central PMCID: 3641655.
8. Kramer J.H., Mungas D., Possin K.L., Rankin K.P., Boxer A.L., Rosen H.J., et al. NIH EXAMINER: conceptualization and development of an executive function battery. JInt Neuropsychol Soc 2013 Oct 8, 1-9. PubMed PMID: 24103232.
9. Possin K.L., Lamarre A.K., Wood K.A., Mungas D.M., Kramer J.H. Ecological validity and neuroanatomical correlates of the NIH EXAMINER Executive Composite Score. JInt Neuropsychol Soc 2013 Jun 14, 1-9. PubMed PMID: 23764015.
10. Possin K.L., Feigenbaum D., Rankin K.P., Smith G.E., Boxer A.L., Wood K., et al. Dissociable executive functions in behavioral variant frontotemporal and Alzheimer dementias. Neurology 2013 Jun 11, 80(24):2180-2185. PubMed PMID: 23658382. Pubmed Central PMCID: 3721104.
11. You S.C., Geschwind M.D., Sha S.J., Apple A., Satris G., Wood K.A., et al. Executive functions in premanifest Huntington's disease. Mov Disord 2013 Dec 27, 29(3):405-409. PubMed PMID: 24375511.
12. Mungas D., Reed B.R., Kramer J.H. Psychometrically matched measures of global cognition, memory, and executive function for assessment of cognitive decline in older persons. Neuropsychology 2003, 17:380-392.
13. Dirnberger G., Jahanshahi M. Executive dysfunction in Parkinson's disease: a review. JNeuropsychol 2013, 7:193-224.
14. Kudlicka A., Clare L., Hindle J.V. Executive functions in Parkinson's disease: systematic review and meta-analysis. Mov Disord 2011, 26(13):2305-2315.
15. Herrera E., Cuetos F., Ribacoda R. Verbal fluency in Parkinson's disease patients on/off dopamine medication. Neuropsychologia 2012, 50(14):3636-3640.
16. Broeders M., Velseboer D.C., de Bie R., Speelman J.D., Muslimovic D., Post B., et al. Cognitive change in newly-diagnosed patients with Parkinson's disease: a 5-year follow-up study. JInt Neuropsychol Soc 2013, 19:695-708.